 |
1C5W |
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
A |
B |
|
|
 |
1C5X |
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
A |
B |
|
|
 |
1C5Y |
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
A |
B |
|
|
 |
1C5Z |
STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR |
A |
B |
|
|
 |
1D3P |
CRYSTAL STRUCTURE OF HUMAN APLHA-THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 3 |
A |
B |
|
|
 |
1D4P |
CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH 5-AMIDINOINDOLE-4-BENZYLPIPERIDINE INHIBITOR |
A |
B |
|
|
 |
1G37 |
CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH BCH-10556 AND EXOSITE-DIRECTED PEPTIDE |
B |
A |
Trypsin-like serine proteases |
|
 |
1GI7 |
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
A |
B |
|
|
 |
1GI8 |
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
A |
B |
|
|
 |
1GI9 |
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
A |
B |
|
|
 |
1GJ4 |
SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN |
L |
H |
|
|
 |
1GJ7 |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GJ8 |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GJ9 |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GJA |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GJB |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GJC |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GJD |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1LQ8 |
Crystal structure of cleaved protein C inhibitor |
B |
A |
Serpins |
|
 |
1MU6 |
Crystal Structure of Thrombin in Complex with L-378,622 |
A |
B |
|
|
 |
1O3P |
Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors |
A |
B |
|
|
 |
1O5A |
Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) |
A |
B |
|
|
 |
1O5B |
Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) |
A |
B |
|
|
 |
1O5C |
Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) |
A |
B |
|
|
 |
1O5G |
Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) |
L |
H |
|
|
 |
1SB1 |
Novel Non-Covalent Thrombin Inhibitors Incorporating P1 4,5,6,7-Tetrahydrobenzothiazole Arginine Side Chain Mimetics |
L |
H |
|
|
 |
1VR1 |
Specifity for Plasminogen Activator Inhibitor-1 |
L |
H |
|
|
 |
1XMN |
Crystal structure of thrombin bound to heparin |
E |
F |
|
|
 |
2A2X |
Orally Active Thrombin Inhibitors in Complex with Thrombin Inh12 |
L |
H |
|
|
 |
2AFQ |
1.9 angstrom crytal structure of wild-type human thrombin in the sodium free state |
A |
B |
|
|
 |
2ANK |
orally active thrombin inhibitors in complex with thrombin and an exosite decapeptide |
L |
H |
|
|
 |
2ANM |
Ternary complex of an orally active thrombin inhibitor with human thrombin and a c-terminal hirudin derived exo-sit inhibitor |
L |
H |
|
|
 |
2GDE |
Thrombin in complex with inhibitor |
L |
H |
|
|
 |
2UUF |
THROMBIN-HIRUGEN BINARY COMPLEX AT 1.26A RESOLUTION |
A |
B |
|
|
 |
2UUJ |
THROMBIN-HIRUGEN-GW473178 TERNARY COMPLEX AT 1.32A RESOLUTION |
A |
B |
|
|
 |
2UUK |
THROMBIN-HIRUGEN-GW420128 TERNARY COMPLEX AT 1.39A RESOLUTION |
A |
B |
|
|
 |
2V3H |
THROMBIN WITH 3-CYCLE NO F |
I |
H |
|
|
 |
2V3O |
THROMBIN WITH 3-CYCLE WITH F |
I |
H |
|
|
 |
3DY0 |
Crystal Structure of Cleaved PCI Bound to Heparin |
B |
A |
|
|